Chennai, Dec 19 : Drug major Sun Pharmacuetical Industries Ltd on Saturday said it has received a warning letter from USFDA relating to its facility in Halol in Gujarat.
Chennai, Dec 14 : Drug maker Sun Pharmaceutical Industries Ltd on Monday said it is selling off one of its plants in the US for an undisclosed sum.
Chennai, Dec 9 : Fortis Healthcare has extended itsaid to the victims of the recent torrential rains and flooding that has altered the landscape of Chennai in the past few weeks.
New Delhi, Nov 26 : Asia's leading healthcare platform Practo on Thursday announced the launch of Practo Ray -- a customised app that will provide specialty specific modules for physicians, paediatricians and dentists to begin with.
New Delhi, Nov 26 : Members of the All India Organisation of Chemists and Druggists (AIOCD) will go on an indefinite strike from mid-December as the government has failed to stop the online sale of drugs through various e-pharmacies, an AIOCD official said on Thursday..
New York, Nov 24 : In one of the biggest deals in the medical world, US-based global drug major Pfizer Inc announced acquiring leading Irish pharma firm Allergan plc for a whopping USD 160 billion.
New Delhi, Nov 19 : AIIMS in collaboration with France-based FAM-Medical Academy Foundation and the French embassy in India has decided to develop cheaper medicines for cancer and cardiovascular diseases.
New Delhi, Nov 15 : Union Health Minister J.P. Nadda on Sunday inaugurated India's first retail facility at AIIMS to provide drugs for cancer and cardiovascular diseases at highly discounted rates.
Kolkata, Nov 12 : The Indian Pharmaceutical Association's West Bengal chapter on Thursday urged the union health ministry to take steps to limit the use of antibiotics as growth promoters in livestock in the wake of increasing antibiotic resistance in India.
Chennai, Nov 5 : Boosted by the sale of its over-the-counter division pharmaceutical player, Novartis India Ltd on Thursday said it closed the second quarter with a net profit of Rs.103.4 crore.
Chennai, Nov 5 : Cipla Ltd on Thursday said it closed the second quarter of the current fiscal with a profit of Rs.407.38 crore.
Chennai, Nov 3 : Sun Pharmaceutical Industries Ltd on Tuesday said it has successfully completed the acquisition of US based ophthalmic drug maker InSite Vision Inc.
Hyderabad, Nov 2 : Strengthening its over the counter (OTC) portfolio, Pharma major Dr. Reddy's Laboratories on Monday announced the launch of Nise D spray, which offers quick and targeted pain killing.
Chennai, Oct 29 : Pharmaceutical major Dr Reddys Laboratories Ltd said on Thursday it closed the second quarter with a net profit of Rs.647.52 crore as against Rs.433.59 crore in the same period last year.
New Delhi, Oct 22 : Innovative technologies, new trends and products from all over India will be exhibited at the two-day Indian Pharma Expo 2015 (IPE) beginning here on October 24, a statement said.
Chennai, Oct 22 : Cadila Healthcare Ltd on Thursday said it closed the second quarter with Rs.614 crore net profit.
New Delhi, Oct 14 : Patients bore the brunt as nearly eight lakh chemist shops in the country were shut on Wednesday in a nationwide strike by the All India Organization of Chemists and Druggists (AIOCD) to protest against the online sale of drugs.
New Delhi, Oct 14 : Over 6,800 chemist shops across Delhi and its adjoining areas were shut on Wednesday following the nationwide strike by the All India Organization of Chemists and Druggists (AIOCD) to protest against the online sale of drugs.
New Delhi, Oct 7 : The Delhi High Court on Wednesday restrained Mumbai-based Glenmark Pharmaceuticals Ltd from making or selling its generic anti-diabetes drugs Zita and Zita-Met while holding it infringing patent of a US drug maker Merck, Sharp and Dohme Corporation.
Chennai, Sep 29 : India's Sun Pharmaceutical Industries Ltd (Sun Pharma) on Tuesday announced that has started a tender offer through Thea Acquisition Corporation - an indirect wholly owned subsidiary- for outstanding shares of the US-based InSite Vision.
Mumbai, Sep 28 : Indian drug major Sun Pharmaceutical's scrip plunged 3.42 percent or 30.50 points on Monday, after the US Food and Drug Administration (FDA) rescinded its earlier approval for a drug launch.
Hyderabad, Sep 25 : Dr. Reddy's Laboratories and Australian drug discovery and development company Alchemia have entered into a USD 17.5 million agreement giving the former worldwide exclusive intellectual property rights for anti-coagulant drug, a statement said on Friday.
Chennai, Sep 19 : Indian drug major Sun Pharmaceutical Industries Ltd will sell its two divisions operating in the central nervous system (CNS) segment to Strides Arcolab Ltd for Rs.165 crore.
Chennai, Sep 17 : Indian pharmaceutical majors are expected to be on the lookout for more overseas buys as domestic drug makers have joined the consolidation phase in the global pharma industry, a research report form Jefferies states.
Chennai, Sep 16 : India's Sun Pharmaceutical Industries Ltd on Wednesday said one of its subsidiaries has entered into an agreement to acquire and merge with it the US- based ophthalmic drug maker InSite Vision Inc.
Hyderabad, Sep 14 : Pharma major Dr. Reddy's Laboratories on Monday announced the signing of a multi-million dollar commercialisation deal with Hatchtech, an Australian pharmaceutical company developing an anti-headlice Xeglyze lotion.
Toronto, Sep 8 : Health Canada has lifted an 11-month-old ban it imposed on import of pharmaceuticals from two India-based firms after a re-inspection found "satisfactory progress", media reported on Tuesday.
Kolkata, Aug 21 : India's pharmaceutical sector can grow five times in the next 10 to 15 years and innovation should act as a catalyst in the growth process, a senior official said here on Friday.
Chennai, Aug 20 : Stock prices of Sun Pharmaceutical Industries Ltd flared up on Thursday against the back drop of the company getting US FDA approval for a dermatology product.
Chennai, Aug 20 : Pharmaceutical major Lupin Ltd on Thursday said it has got the USFDA approval for anti-cholesterol tablet though a sector analyst said the drug may not contribute to the company's financials majorly.
Chennai, Aug 20 : Lupin Ltd's anti-cholesterol drug securing USFDA approval is a positive development but may not contribute to the company's financials in a major way, said stock broking company Angel Broking.
Chennai, Aug 20 : Stock prices of Sun Pharmaceutical Industries Ltd flared up on Thursday on the back drop of the company getting US FDA approval for a dermatology product.
New Delhi, Aug 11 : The Delhi government on Tuesday decided to ban the sale of all blood-thinning pills like aspirin and brufen without prescription in the national capital.
Accra (Ghana), Aug 4 : The Indian pharmaceutical industry sees good prospects for growth in Africa, with the sector having quintupled in size in terms of value in just over a decade, and expected to grow to upwards of USD50 billion by 2020, according to an international consulting firm.
Mumbai, July 23 : Indian pharmaceuticals company Lupin Limited on Thursday said it has entered into a definitive agreement to acquire US-based privately-held company Gavis Pharmaceuticals LLC and Novel Laboratories Inc.
Bengaluru, July 22 : Glenmark Pharmaceuticals Limited here on Wednesday launched its advanced diabetes treatment molecule Teneligliptin under the brands Ziten and Zita plus, priced at Rs.19.90 per tablet and enough for a day's treatment.
Mumbai, July 22 : A majority of Indian pharma companies, both multinational and domestic, are yet to exploit the huge opportunities offered on various digital platforms to connect with their stakeholders effectively, a new study said on Wednesday.
Mumbai, July 20 : Drug major Sun Pharmaceutical Industries Ltd on Monday admitted that its consolidated revenue and profit for fiscal 2015-16 would be impacted by its integration with Ranbaxy Laboratories it bought for USD 3.2 billion last year.
Mumbai, July 15 : : Pharma major Pfizer Ltd announced on Wednesday the shutting down of its Thane manufacturing plant from September 16 as it has become unviable, a company spokesperson said here.
Kolkata, June 30 : MedPlus, a pharmacy retailers with over 1300 stores spread across 12 states, on Tuesday announced the launch of their innovative e-commerce service 'Click, Pick. Save.' in Kolkata.
Kolkata, June 30 : Hyderabad-based pharmacy chain, MedPlus Health Services on Tuesday said it is aiming to raise between USD60-75 million to fuel pan-India expansion plans.
Lucknow, June 29 : Apex industry body Assocham on Monday said that Uttar Pradesh was fast emerging as a cost-effective manufacturing centre for medical and dental instruments.
Bengaluru, June 29 : India's pharma major Dr Reddy's Laboratories Ltd has voluntarily recalled from the US market two medicines including one used to treat seizures like epilepsy on the advice of the regulator, an official statement said.
New Delhi, June 23 : Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (US FDA) for Levofloxacin Tablets, 250mg and 500mg, the generic version of Levaquin Tablets (of Ortho-McNeil), which is used for the treatment of adults with infections such as pneumonia, bacterial sinusitis, chronic bronchitis, skin and skin structure infections, chronic bacterial prostatitis, urinary tract infections and inhalational anthrax.
Bengaluru, June 23 : Leading Indian drug maker Jubilant Life Sciences Tuesday announced it had received approval of the US Food and Drug Administration (FDA) for its tablets used in treating adults for various infections, including pneumonia.
New Delhi, June 23 : At USD2.5-3.1 billion, pharmaceutical outsourcing market, excluding contract manufacturing services, accounts for about 75 percent of the India's medical process outsourcing (MPO) segment, a study stated here on Tuesday.
Hyderabad, June 19 : Drug maker Dr Reddy's on Friday announced the launch of HAiROOTZ, the first hair growth supplement to be marketed in India as over-the-counter (OTC) by the company.
Bengaluru, June 11 : Indian subsidiary of British pharma major AstraZeneca on Thursday unveiled a new drug to treat Type-2 diabetes mellitus.
Kolkata, May 22 : Drug major Lupin will be replacing integrated power company, Tata Power Co Ltd in the S and P BSE Sensex from June 22.
Mumbai, May 21 : The British subsidiary of Indian drug major Cipla Ltd has acquired 51 percent equity stake in Uganda-based Quality Chemicals Ltd for USD30 million (Rs.191 crore) in tranches from its current shareholders.
Hyderabad, May 20 : The U.S. Pharmacopeial Convention (USP), a global leader in medicines quality, is bringing together national medicines control laboratory officials for a workshop on May 26-28 in Hyderabad at USP-India on improving aspects of medicines quality in the Asia-Pacific region.
New Delhi, May 13 : Drug major Lupin posted consolidated net profit of Rs.547 crore for the quarter ended March 31, 2015 compared to Rs.553 crore posted during the corresponding quarter a year back.
London, May 13 : Many fixed-dose drug combinations (FDCs) in India lack central regulatory approval despite concerns over the safety and efficacy of such combinations, say British researchers.
New Delhi /Kolkata, Apr 21 : Cirrius PharmaCRM Digital Platform on Microsoft Azure has been adopted by leading pharmaceutical companies such as Cipla, Ranbaxy and Biocon for enabling multi-channel digitization of medical engagements.
Mumbai, April 20 : The Canadian subsidiary of Mumbai-based pharmaceuticals firm Lupin Limited on Monday said it has launched its first brand product Zaxine in that country under a strategic licensing agreement.
Mumbai, March 26 : India's largest pharma company Sun Pharmaceutical Industries on Wednesday announced the closure of its merger with Ranbaxy Laboratories saying the integration will deliver synergies worth USD 250 million (over Rs.1,500 crore) in three years.
Kolkata, March 16 : Indian pharmaceuticals companies need to diversify their product range and focus on evolving as innovators as growth in generic market is expected to slow down over the next decade, a study by industry body Assocham said on Monday.
Mumbai, March 16 : Mumbai-based drug maker Lupin on Monday said it is in the process of acquiring the balance 40 percent stake in South African generics major Pharma Dynamics (PD).
Mumbai/Kolkata, March 11 : Market regulator Securities and Exchange Board of India (SEBI) on Wednesday prohibited Kolkata-based Asoka Lifescience Ltd. (ALL) from mobilising funds through issuance of securities as well as accessing capital markets on grounds of alleged illicit fund-raising activities.
Hyderabad, Feb 28 : Pharma major Dr. Reddy's Laboratories has said that the union budget for 2015-16 has set the stage for growth in the medium to long term.